リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Acute Coronary Syndrome Due to Intraplaque Hemorrhage in a Post-gastrectomy Patient with a Latent Severe Glycemic Disorder」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Acute Coronary Syndrome Due to Intraplaque Hemorrhage in a Post-gastrectomy Patient with a Latent Severe Glycemic Disorder

Yamamoto, Hiroyuki Takaya, Tomofumi Emoto, Takuo Takeda, Shintaro Yoshida, Naofumi Sawada, Takahiro Yamashita, Tomoya Hirata, Ken-ichi Kawai, Hiroya 神戸大学

2023.02.01

概要

Glycemic disorders involving large glucose fluctuations and recurrent hypoglycemia may lead to adverse cardiovascular events, including acute coronary syndrome (ACS). Flash glucose monitoring (FGM) has reportedly been useful for detecting latent glycemic disorders. However, only a few studies have so far reported latent glycemic disorders in coronary artery disease. Thus, we herein present a unique case of ACS due to intraplaque hemorrhage in a post-gastrectomy patient who had no apparent coronary risk, except for a latent severe glycemic disorder detected via FGM. This masked etiology should be considered in ACS patients who have no apparent cardiovascular risks in order to improve their cardiovascular outcomes.

この論文で使われている画像

参考文献

1. Takahashi H, Iwahashi N, Kirigaya J, et al. Glycemic variability

determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome. Cardiovasc Diabetol

17: 116, 2018.

2. Yamamoto H, Shinke T, Otake H, et al. Impact of daily glucose

fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease

undergoing lipid-lowering therapy. J Diabetes Investig 12: 10151024, 2021.

3. Kumagai R, Muramatsu A, Fujii M, et al. Comparison of glucose

monitoring between Freestyle Libre Pro and iPro2 in patients with

diabetes mellitus. J Diabetes Investig 10: 851-856, 2019.

4. Kuroda M, Shinke T, Sakaguchi K, et al. Effect of daily glucose

fluctuation on coronary plaque vulnerability in patients pre-treated

with lipid-lowering therapy: a prospective observational study.

JACC Cardiovasc Interv 8: 800-811, 2015.

5. Gohbara M, Hibi K, Mitsuhashi T, et al. Glycemic variability on

continuous glucose monitoring system correlates with non-culprit

vessel coronary plaque vulnerability in patients with first-episode

acute coronary syndrome - optical coherence tomography study.

Circ J 80: 202-210, 2016.

6. Kitani S, Igarashi Y, Tsuchikane E, et al. Efficacy of drug-coated

balloon angioplasty after directional coronary atherectomy for

coronary bifurcation lesions (DCA/DCB registry). Catheter Cardiovasc Interv 97: E614-E623, 2021.

7. Vos NS, Fagel ND, Amoroso G, et al. Paclitaxel-coated balloon

angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial. JACC Cardiovasc Interv

12: 1691-1699, 2019.

8. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on

acute coronary syndromes: the pathologists’ view. Eur Heart J 34:

719-728, 2013.

9. Matsumura M, Mintz GS, Kang SJ, et al. Intravascular ultrasound

and near-infrared spectroscopic features of coronary lesions with

12.

13.

14.

15.

16.

17.

18.

intraplaque haemorrhage. Eur Heart J Cardiovasc Imaging 18:

1222-1228, 2017.

Kubota T, Shoda K, Ushigome E, et al. Utility of continuous glucose monitoring following gastrectomy. Gastric Cancer 23: 699706, 2020.

Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233-240, 1999.

International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology,

pathogenesis, and management. Lancet Diabetes Endocrinol 7:

385-396, 2019.

Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention

of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Lancet 359: 2072-2077.

Yamamoto H, Konishi A, Shinke T, et al. The impact of

vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery

disease: VOGUE-A multicenter randomized controlled trial. BMC

Cardiovasc Disord 21: 92, 2021.

Catan A, Turpin C, Diotel N, et al. Aging and glycation promote

erythrocyte phagocytosis by human endothelial cells: potential impact in atherothrombosis under diabetic conditions. Atherosclerosis

291: 87-98, 2019.

Costa PZ, Soares R. Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. Life Sci 92: 10371045, 2013.

Chen Y, Waqar AB, Nishijima K, et al. Macrophage-derived

MMP-9 enhances the progression of atherosclerotic lesions and

vascular calcification in transgenic rabbits. J Cell Mol Med 24:

4261-4274, 2020.

Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein

endothelial cells in culture. Am J Physiol Endocrinol Metab 281:

E924-E930, 2001.

The Internal Medicine is an Open Access journal distributed under the Creative

Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To

view the details of this license, please visit (https://creativecommons.org/licenses/

by-nc-nd/4.0/).

Ⓒ 2023 The Japanese Society of Internal Medicine

Intern Med 62: 399-403, 2023

403

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る